Bioorthogonally catalyzed lethality strategy generates targeting drugs within tumor

(Science China Press) Selectively killing tumor while not causing damage to normal cells still remains a challenge in cancer chemotherapy. Professor Hongke Liu from Nanjing Normal University together with Professor Jing Zhao and Professor Zijian Guo from Nanjing University developed a novel strategy---bioorthogonally-catalyzed lethality to generate efficient anticancer species between two non-toxic components only within cancer cells and tumors without external catalysts, realizing the precise and efficient anticancer chemotherapy.
Source: EurekAlert! - Biology - Category: Biology Source Type: news